No abstract available
Publication types
-
Clinical Trial, Phase III
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Disease Progression
-
Disease-Free Survival
-
Humans
-
Leukemia / blood
-
Leukemia / diagnosis
-
Leukemia / drug therapy
-
Lymphoma, Follicular / blood
-
Lymphoma, Follicular / diagnosis
-
Lymphoma, Follicular / drug therapy*
-
Neoplastic Cells, Circulating / metabolism
-
Prognosis
-
Proportional Hazards Models
-
Rituximab
-
Time Factors
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Rituximab